.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers recently conducted a prospective randomized study to evaluate the SR2000 robotic surgical system against the industry-standard Da Vinci Xi. The study focused on patients undergoing robot-assisted partial nephrectomy (RAPN). Consequently, the results provide critical insights for urologists considering domestic robotic platforms as viable alternatives to established systems.
The analysis included 90 patients randomized between the two surgical systems. Notably, the researchers found no significant differences in docking time, operative time, length of hospital stay, or intraoperative blood loss. All 90 procedures were completed successfully without converting to open or traditional laparoscopic surgery. Additionally, every patient achieved negative surgical margins, ensuring high standards of oncological safety.
One of the most significant findings involves the transition process for experienced robotic surgeons. While many doctors already use the Da Vinci Xi, switching to a new platform often requires specific technical adjustments. The study suggests that Da Vinci-proficient surgeons need about 18 cases to master the SR2000 robotic surgical system.
Furthermore, the domestic group recorded a 23-minute warm ischemia time versus 24 minutes in the Da Vinci group. Although this difference was not statistically significant, it demonstrates that the domestic robot performs reliably during the most critical phases of nephron-sparing surgery. Therefore, the SR2000 appears both safe and effective for complex renal procedures. Its comparable performance metrics suggest it could play a major role in expanding access to robotic urological care.
For surgeons already experienced with the Da Vinci Xi platform, this study indicates that technical proficiency with the SR2000 system is typically achieved after approximately 18 cases.
Yes, the clinical trial showed that both systems had comparable safety profiles. There were no statistically significant differences in blood loss, complication rates, or the achievement of negative surgical margins.
The SR2000 group had a mean warm ischemia time of 23 minutes, compared to 24 minutes in the Da Vinci Xi group. However, researchers noted that this slight difference was not statistically significant (p > 0.05).
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References
Li JQ et al. [A comparative study on perioperative outcomes and learning curves of domestic robot-assisted versus Da Vinci Xi robot-assisted partial nephrectomy]. Zhonghua Wai Ke Za Zhi. 2026 Mar 25. doi: 10.3760/cma.j.cn112139-20250801-00386. PMID: 41881798.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study comparing the China-made SR2000 robotic system and Da Vinci Xi for partial nephrectomy found similar safety, efficacy, and an 18-case learning curve...
5 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
